A recent head-to-head trial reveals that Eli Lilly’s Zepbound leads to greater weight loss compared to Novo Nordisk’s Wegovy, marking a significant development in obesity treatment options.
Tag: obesity
Eli Lilly’s Zepbound Outperforms Wegovy in Weight Loss Trial
A recent head-to-head trial reveals that Eli Lilly’s Zepbound leads to greater weight loss compared to Novo Nordisk’s Wegovy, marking a significant development in obesity treatment options.
Rising Obesity Rates Among Children: A Growing Concern
Experts highlight alarming trends in childhood obesity, emphasizing the need for immediate action to promote healthier lifestyles.